Variables | Patients (n=161 386) n (%) | |
Age group (years) | ||
0–2 | 5332 | (3.30) |
3–5 | 21 312 | (13.21) |
6–9 | 49 079 | (30.41) |
10–12 | 21 026 | (13.03) |
13–19 | 64 637 | (40.05) |
Gender | ||
Male | 94 049 | (58.28) |
Female | 67 337 | (41.72) |
Season | ||
Spring | 35 912 | (22.25) |
Summer | 43 872 | (27.18) |
Autumn | 47 157 | (29.22) |
Winter | 34 445 | (21.34) |
Concomitant medications* | ||
Antihistamines | 117 113 | (72.57) |
Non-steroidal anti-inflammatory drugs | 89 518 | (55.47) |
Corticosteroids | 76 684 | (47.52) |
Histamine H2-receptor antagonists | 30 673 | (19.01) |
Opioids | 18 773 | (11.63) |
Benzodiazepines | 14 317 | (8.87) |
Antipsychotics | 7865 | (4.87) |
Psychostimulants | 7497 | (4.65) |
Neuraminidase inhibitors | 6663 | (4.13) |
Antiepileptics | 2732 | (1.69) |
Antidepressants | 2222 | (1.38) |
Neuropsychiatric adverse events | ||
Anxiety disorder | 47 911 | (29.69) |
Mood disorder | 46 114 | (28.57) |
Personality disorder | 36 899 | (22.86) |
Sleep-related disorder | 10 616 | (6.58) |
Others | 10 194 | (6.32) |
Movement disorder | 7076 | (4.38) |
Psychotic disorder | 1469 | (0.91) |
Cognitive disorder | 1087 | (0.67) |
Self-harm | 20 | (0.01) |
*Overalpped.